Neurorehabilitation News

The FDA has granted orphan drug designation to a small molecule therapeutic for individuals with Fragile X syndrome.

Enveric Biosciences announced it has signed a nonbinding term sheet to out-license a class of novel psilocin prodrugs to MindBio Therapeutics, an agreement that could yield more than $66 million in sales.

A health care innovation company and a clinical-stage biotech company have announced a partnership to advance a novel apomorphine therapeutic in combination with a wearable drug delivery platform to treat Parkinson’s disease.

DENVER — Efficacy of fumarates to treat multiple sclerosis was consistent across four racial and ethnic groups, particularly for Black, Hispanic and Asian persons, according to a poster at the American Academy of Neurology annual meeting.

DENVER — A combination therapy of ciprofloxacin and celecoxib demonstrated a favorable safety profile for those with amyotrophic lateral sclerosis, Merit Cudkowicz, MD, MSc, said in this Healio video.

Teva Pharmaceuticals and Medincell have announced positive efficacy results from the phase 3 SOLARIS clinical trial evaluating an investigational, monthly subcutaneous injectable in adults with schizophrenia.

Topcon Healthcare has partnered with Microsoft Corp. to create “Healthcare from the Eye,” an AI-powered solution developed to improve health care by prescreening patients for systemic and neurological diseases via a noninvasive eye scan.

The FDA has granted breakthrough therapy designation to a proprietary oligonucleotide conjugate for the treatment of myotonic dystrophy type 1, according to the manufacturer.

For patients diagnosed with intracerebral hemorrhage, surgical intervention within 24 hours led to better functional outcomes at 180 days compared with medical management alone, researchers wrote in the New England Journal of Medicine.

DENVER — Experiences and concerns about treatment, diagnosis, care, cost and quality of life among Black and Hispanic patients with myasthenia gravis were more negative compared with their Asian and white counterparts, according to research.